• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心脏病专家与黏多糖贮积症。意大利代谢性疾病心脏病学专家小组(GICEM)关于诊断、随访及心脏管理的建议]

[Cardiologists and mucopolysaccharidoses. Recommendations of GICEM (Cardiology Experts on Metabolic Disease Italian Group) for diagnosis, follow-up and cardiological management].

作者信息

Russo Pierluigi, Andria Generoso, Baldinelli Alessandra, Boffi Maria Lucia, Cerini Emma, Della Casa Roberto, Imperatori Andrea, Luciani Giovanni Battista, Morra Elisa, Parini Rossella, Pieroni Maurizio, Prioli Maria Antonia, Ragni Luca, Rapezzi Claudio, Rinelli Gabriele, Rubino Marta, Sarais Cristiano, Sciacca Pietro, Seddio Francesco, Limongelli Giuseppe

机构信息

U.O. Assistenza Specialistica, Distretto Socio-Sanitario Trani-Bisceglie, Ambulatorio di Cardiologia Pediatrica e delle Cardiopatie Congenite e Genetiche nell'Adulto, Trani (BT) - GICEM Core Writers Cardiologi.

Sezione di Pediatria, Dipartimento di Scienze Mediche Traslazionali, Università degli Studi "Federico II", Napoli - GICEM Core Writers Metabolisti.

出版信息

G Ital Cardiol (Rome). 2017 Sep;18(9):638-649. doi: 10.1714/2741.27947.

DOI:10.1714/2741.27947
PMID:28845875
Abstract

Mucopolysaccharidoses (MPS) represent a group of rare lysosomal storage disorders, with a heterogeneous clinical presentation in terms of inheritance (autosomal and X-linked recessive), age of onset (infants, children, and adults), systemic and cardiac manifestations (mild to severe disease forms). Evidence-based recommendations on the diagnosis and management of cardiovascular disease in MPS are scarce. GICEM (Gruppo Italiano Cardiologi Esperti Malattie Metaboliche) is a group of cardiologists, cardiac surgeons and pediatricians with a specific expertise in metabolic diseases including MPS. In this paper, we report our experience and recommendations on the diagnosis and management of cardiovascular aspects in MPS, with a tailored approach based on current evidence, and taking into account MPS phenotype (particularly, I, II, IVa, VI), age at presentation, and severity of systemic and cardiac manifestations.

摘要

黏多糖贮积症(MPS)是一组罕见的溶酶体贮积症,在遗传方式(常染色体隐性和X连锁隐性)、发病年龄(婴儿、儿童和成人)、全身和心脏表现(从轻度到重度疾病形式)方面具有异质性临床表现。关于MPS中心血管疾病诊断和管理的循证推荐很少。GICEM(意大利代谢疾病专家心脏病学小组)是一群在包括MPS在内的代谢疾病方面具有专业特长的心脏病学家、心脏外科医生和儿科医生。在本文中,我们报告了我们在MPS心血管方面诊断和管理的经验及推荐,采用基于当前证据的定制方法,并考虑到MPS表型(特别是I型、II型、IVa型、VI型)、就诊年龄以及全身和心脏表现的严重程度。

相似文献

1
[Cardiologists and mucopolysaccharidoses. Recommendations of GICEM (Cardiology Experts on Metabolic Disease Italian Group) for diagnosis, follow-up and cardiological management].[心脏病专家与黏多糖贮积症。意大利代谢性疾病心脏病学专家小组(GICEM)关于诊断、随访及心脏管理的建议]
G Ital Cardiol (Rome). 2017 Sep;18(9):638-649. doi: 10.1714/2741.27947.
2
Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.黏多糖贮积症心脏表现的早期诊断和管理:儿科和成人心脏病学家实用指南。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):122. doi: 10.1186/s13052-018-0560-3.
3
Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.黏多糖贮积症 I 型、II 型、IVA 型和 VI 型患者的心脏结构与功能以及酶替代疗法的效果
Mol Genet Metab. 2016 Apr;117(4):431-7. doi: 10.1016/j.ymgme.2016.02.003. Epub 2016 Feb 16.
4
The mucopolysaccharidoses: advances in medical care lead to challenges in orthopaedic surgical care.黏多糖贮积症:医疗护理的进步给骨科手术护理带来挑战。
Bone Joint J. 2017 Sep;99-B(9):1132-1139. doi: 10.1302/0301-620X.99B9.BJJ-2017-0487.
5
Ocular features in mucopolysaccharidosis: diagnosis and treatment.黏多糖贮积症的眼部特征:诊断与治疗。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.
6
[Neurologic manifestations in mucopolysaccharidoses].[黏多糖贮积症的神经学表现]
Arch Pediatr. 2014 Jun;21 Suppl 1:S14-21. doi: 10.1016/S0929-693X(14)72254-7.
7
Overview of the mucopolysaccharidoses.黏多糖贮积症概述。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v4-12. doi: 10.1093/rheumatology/ker394.
8
Mucopolysaccharidoses: anesthetic considerations and clinical manifestations.黏多糖贮积症:麻醉注意事项及临床表现
Middle East J Anaesthesiol. 2011 Jun;21(2):243-50.
9
Cardiac structural involvement in mucopolysaccharidoses.黏多糖贮积症中的心脏结构受累情况。
Cardiology. 2002;98(1-2):18-20. doi: 10.1159/000064674.
10
Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs.成人黏多糖贮积症患者的心脏问题:当前认知与新出现的需求
Heart. 2016 Aug 15;102(16):1257-62. doi: 10.1136/heartjnl-2015-309258. Epub 2016 Apr 21.

引用本文的文献

1
Evaluation of cardiac findings in mucopolysaccharidosis.黏多糖贮积症的心脏表现评估。
Int J Cardiovasc Imaging. 2024 Jan;40(1):73-78. doi: 10.1007/s10554-023-02983-y. Epub 2023 Oct 17.
2
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study.MPS 患者的心脏受累:意大利多中心研究中的发生率和治疗反应。
Orphanet J Rare Dis. 2022 Jun 29;17(1):251. doi: 10.1186/s13023-022-02396-5.
3
Diagnosis of Mucopolysaccharidoses.黏多糖贮积症的诊断
Diagnostics (Basel). 2020 Mar 22;10(3):172. doi: 10.3390/diagnostics10030172.
4
Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.黏多糖贮积症心脏表现的早期诊断和管理:儿科和成人心脏病学家实用指南。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):122. doi: 10.1186/s13052-018-0560-3.